levofloxacin has been researched along with Hepatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Graf, K; Kaden, T; Li, R; Mosig, AS; Raasch, M; Rennert, K | 1 |
| Fukuda, H; Fukuda, S; Irie, M; Kunimoto, H; Morihara, D; Sakisaka, S; Shakado, S; Takata, K; Takeyama, Y; Tanaka, T; Umeda, K; Yamauchi, R; Yokoyama, K | 1 |
| Andrade, RJ; Carrascosa, MF; Caviedes, JR; Lavín, AC; Lucena, MI; Mones, JC; Rivero, AP; Serrano, VB | 1 |
1 review(s) available for levofloxacin and Hepatitis
| Article | Year |
|---|---|
Fitz-Hugh-Curtis syndrome in a man positive for Chlamydia trachomatis.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydia trachomatis; Drug Therapy, Combination; Duodenal Ulcer; Hepatitis; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Pelvic Inflammatory Disease; Peritonitis; Urine | 2018 |
2 other study(ies) available for levofloxacin and Hepatitis
| Article | Year |
|---|---|
Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model.
Topics: Animals; Cytokines; Drug-Related Side Effects and Adverse Reactions; Endothelial Cells; Fluoroquinolones; Hepatitis; Humans; Levofloxacin | 2023 |
Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Doxycycline; Fatal Outcome; Hepatitis; Humans; Levofloxacin; Liver Failure, Acute; Male; Middle Aged; Naproxen; Ofloxacin; Pericarditis; Pneumonia, Mycoplasma | 2009 |